Living-donor parathyroid allotransplantation for therapy-refractory postsurgical persistent hypoparathyroidism in a nontransplant recipient – three year results: a case report

BMC Surgery

Case Report

Christiane Girlich¹  Fabian Eder²  Ernst-Michael Jung³  Ayman Agha⁴  Hans Juergen Schlitt⁴  Marcus Nils Scherer⁴  Christian Moser⁴  Andreas Schaeffler⁵  Thomas Karrasch⁵ 

[1] Department of Internal Medicine I, University Hospital Regensburg, D-93053, Regensburg, Germany;Department of Pathology, University Hospital Regensburg, D-93053, Regensburg, Germany;Department of Radiology, University Hospital Regensburg, D-93053, Regensburg, Germany;Department of Surgery, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, D-93053, Regensburg, Germany;Medical Clinic and Policlinic III, University Hospital Giessen, D-35392, Giessen, Germany;

关键词: Hypoparathyroidism;    Hypocalcemia;    Living-donor parathyroid allotransplantation;    Immunosuppression;   

DOI  :  10.1186/s12893-016-0165-y

 received in 2016-02-15, accepted in 2016-07-22,  发布年份 2016

来源: Springer

【 摘 要 】

BackgroundTherapy-refractory persistent hypoparathyroidism after extensive neck surgery is a rare but severe complication. Parathyroid allotransplantation may represent a definitive treatment option.Case presentationA 32-year old female was referred to our hospital with intractable persistent hypocalcemia after neck surgery for papillary thyroid cancer. Despite optimal medical treatment including calcium and vitamin D supplementation and even hormonal replacement therapy hypocalcemic symptoms failed to improve. The quality of life was considered very low. In light of the unsuccessful medical therapy and the young age of the patient parathyroid allotransplantation seemed an attractive treatment option to restore normal calcium homeostasis despite of the need for immunosuppressive therapy after the procedure. Therefore, we performed living-donor allotransplantation of two healthy parathyroid glands to the recipient’s left forearm. The surgical intervention was successful. Neither the donor nor the recipient showed any complications. In the postoperative course clinical symptoms of hypocalcemia significantly improved whereas serum calcium and parathyroid hormone (PTH) levels progressively increased into the normal range. Former intense replacement therapy could be discontinued completely in a stepwise fashion. To date, nearly three years after transplantation, the patient remains asymptomatic with normal serum levels of calcium and PTH.ConclusionSuccessful living-donor parathyroid allotransplantation for postsurgical hypoparathyroidism represents an innovative therapeutic strategy that could provide the definitive treatment in those patients in which the disease is therapy-refractory. The procedure can be justified even in nontransplant recipients. Retrieval of parathyroid glands from healthy donors is feasible and safe.

【 授权许可】

CC BY   
© The Author(s). 2016